About CHO Plus

CHO Plus is creating regulatory compliant genetically engineered mammalian cells to be used by biopharmaceutical companies for therapeutic protein manufacturing. Early proof of concept experiments demonstrate CHO Plus cells to be 4.5-fold more productive than parent cells in model system. The CHO Plus approach includes patent-pending methods for genetically engineering mammalian cells; proprietary and patent-pending targeted transfection technology; and efficient clone screening technology.